Shares in vaccine developers jumped on Tuesday after the US reported its first human death from the H5 strain of bird flu. Moderna’s stock rose 6 per cent, Novavax gained more than 12 per cent and ...

The complaint alleges nearly two dozen pharmaceutical companies colluded to limit competition, causing costs for certain generic medications to skyrocket.

The company is one of a few drugmakers currently developing a vaccine for the illness, which is spreading rapidly through ...